ellacor
Asset
Micro-coring technology that removes micro-columns of skin to reduce skin laxity and wrinkles
- Stage
- Human trials
- Modality
- Device
- Target
- Not known
- 3
- Indications
- 1
- Trial
- 1
- Developer
Indications
3Gene expression
Human trials, Completed, NCT07224880, clinicaltrials.gov, 7 Oct 2026
Glp1 agonist
Human trials, Completed, NCT07224880, clinicaltrials.gov, 7 Oct 2026
Skin laxity
Human trials, Completed, NCT07224880, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.